de Notaristefani Carlo 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Feb 12, 2018
Insider Transaction Report
Form 4
de Notaristefani Carlo
Executive VP Global Operations
Transactions
- Award
Stock Options (right to buy)
2018-02-09+159,819→ 159,819 totalExercise: $18.61Exp: 2028-02-08→ Ordinary Shares (159,819 underlying) - Award
Restricted Share Units
2018-02-09+62,690→ 62,690 total→ Ordinary Shares (62,690 underlying)
Footnotes (4)
- [F1]Stock options were granted on February 9, 2018, with 53,273 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F3]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F4]Restricted share units were granted on February 9, 2018, with 20,896 vesting on each of February 9, 2020 and February 9, 2021 and 20,898 vesting on February 9, 2022.